July 12, 2022 11:13 AM EDT
News Briefing

Con­nect shrinks time­line for atopic der­mati­tis da­ta; Bi­cy­cle's wheels keep turn­ing with Genen­tech

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Con­nect Bio­phar­ma has pushed up the time­line on re­leas­ing topline da­ta for its lead can­di­date, be­ing test­ed in Chi­na, for atopic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

No­vo Nordisk’s once-dai­ly he­mo­phil­ia drug Al­he­mo ap­proved in US

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

GSK's Ze­ju­la-Jem­per­li com­bo in ovar­i­an can­cer hits pri­ma­ry end­point, miss­es on over­all sur­vival

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times